Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
Abstract
We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology clinic for evaluation and management of severe, chronic hypomagnesemia because of renal magnesium wasting in combination with frequent diarrhea. Clinical manifestations associated with hypomagnesemia included muscle weakness, cognitive impairment, and frequent seizures. Her hypomagnesemia had persisted for more than 20 years despite maximal oral magnesium supplementation and frequent intravenous magnesium infusions. To provide slower delivery of parenteral magnesium, she was prescribed 2 g/d of magnesium sulfate, delivered subcutaneously. This was well tolerated, rapidly normalized her serum magnesium levels, and improved her symptoms. We briefly discuss modalities used for treatment of hypomagnesemia, including shortcomings of intravenous therapy and limited literature discussing efficacy and tolerability of subcutaneous infusions. This case report demonstrates the efficacy and safety of subcutaneous magnesium infusions in a patient with refractory hypomagnesemia and suggests that subcutaneous infusion may be safe and effective for treatment of refractory hypomagnesemia in other patients with urinary magnesium wasting.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.